59 related articles for article (PubMed ID: 1480742)
1. Clinical status of patients after 10 years of lupus nephritis.
Moroni G; Banfi G; Ponticelli C
Q J Med; 1992 Sep; 84(305):681-9. PubMed ID: 1480742
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
4. [Lupus nephritis in children and adolescents: therapy, clinical course and prognosis].
Bogdanović R; Nikolić V; Ognjanović M; Dimitrijević J; Marković-Lipkovski J; Pasić S; Minić A; Stajić N
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():6-12. PubMed ID: 12583307
[TBL] [Abstract][Full Text] [Related]
5. The long-term outcome of 93 patients with proliferative lupus nephritis.
Moroni G; Quaglini S; Gallelli B; Banfi G; Messa P; Ponticelli C
Nephrol Dial Transplant; 2007 Sep; 22(9):2531-9. PubMed ID: 17510096
[TBL] [Abstract][Full Text] [Related]
6. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
7. Longterm followup of childhood lupus nephritis.
Hagelberg S; Lee Y; Bargman J; Mah G; Schneider R; Laskin C; Eddy A; Gladman D; Urowitz M; Hebert D; Silverman E
J Rheumatol; 2002 Dec; 29(12):2635-42. PubMed ID: 12465165
[TBL] [Abstract][Full Text] [Related]
8. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
[TBL] [Abstract][Full Text] [Related]
9. [Lupus nephritis: retrospective analysis of the course of the disease].
Djukanović L; Pavlović S; Blagojević R; Dimitrijević J; Stojsic T; Ratković M; Kazić K; Lezaić V; Naumović R
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
[TBL] [Abstract][Full Text] [Related]
12. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
[TBL] [Abstract][Full Text] [Related]
13. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up.
Moroni G; Gallelli B; Quaglini S; Banfi G; Rivolta E; Messa P; Ponticelli C
Nephrol Dial Transplant; 2006 Jun; 21(6):1541-8. PubMed ID: 16455674
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognosis of diffuse lupus nephritis.
Ponticelli C; Zucchelli P; Moroni G; Cagnoli L; Banfi G; Pasquali S
Clin Nephrol; 1987 Dec; 28(6):263-71. PubMed ID: 3327639
[TBL] [Abstract][Full Text] [Related]
16. [Intermittent intravenous administration of cyclophosphamide in patients with lupus nephritis].
Morović-Vergles J; Galesić K; Dancuo I; Vergles D
Acta Med Croatica; 2004; 58(1):13-7. PubMed ID: 15125388
[TBL] [Abstract][Full Text] [Related]
17. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
[TBL] [Abstract][Full Text] [Related]
18. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[TBL] [Abstract][Full Text] [Related]
19. [Development of lupus nephritis in childhood].
Ghio L; Edefonti A; Cohen E; Giani M; Miglioli E; Bardare M
Pediatr Med Chir; 1986; 8(3):325-8. PubMed ID: 3786194
[TBL] [Abstract][Full Text] [Related]
20. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
